03/12/2025 00:11
|
Medical, Health & Aged Care
* Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025
* The Phase 2 expansion will evaluate 160 MBq and 200 MBq doses of...